iShares Biotechnology ETF
IBB
IBB
609 hedge funds and large institutions have $6.14B invested in iShares Biotechnology ETF in 2018 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 171 increasing their positions, 227 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
609
Holders Change
+1
Holders Change %
+0.16%
% of All Funds
13.96%
Holding in Top 10
23
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-8%
% of All Funds
0.53%
New
63
Increased
171
Reduced
227
Closed
59
Calls
$411M
Puts
$495M
Net Calls
-$84.6M
Net Calls Change
+$195M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$491M |
| 2 |
Goldman Sachs
New York
|
$396M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$1.6B |
| 4 |
Citigroup
New York
|
$297M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
$188M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$410M |
| 2 |
JG
Jefferies Group
New York
|
$581K |
| 3 |
NM
NWI Management
New York
|
$0 |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
$59.5M |
| 5 |
SF
Synovus Financial
Columbus,
Georgia
|
$1.68M |
